85-1559-49 [取扱停止]CpG-A DNA, ODN 2216 Prototype, BioGenomics™ 200nmol C7905-80

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • ODN 2216 is a prototype of the class of CpG-A oligodeoxynucleotides (ODN), also known as ‘D’-type ODN, and contains a phosphodiester (PO) backbone. It is particularly effective for activating NK cells and inducing IFN-alpha production in plasmacytoid dendritic cell (PDC) precursors. The vertebrate immune system has evolved innate immune defense pattern recognition receptors (PRRs) that detect unmethylated cytosine-phosphate-guanine (CpG) motifs within bacterial DNA. Cellular activation by CpG motifs occurs via the Toll signal pathway. The Toll-like receptor-9 (TLR9, CD289) appears to be a major component of the CpG-DNA receptor, acting by direct binding to CpG-DNA, which triggers the induction of cell signaling pathways including the mitogen activated protein kinase (MAPKs) and NFκB, leading to stimulation of various cells of the immune system. The human TLR9 is expressed in B cells and PDC. Mice also express TLR9 in the myeloid compartment. Optimal sequences for activating TLR9 vary among species. Synthetic ODN contain CpG-DNA motifs mimicking the immunostimulatory effects of bacterial DNA and can, therefore, be used as immunoprotective agents, vaccine adjuvants and anti-allergic agents. CpG ODN also affects immune tolerance and autoimmunity. Different classes of CpG ODN are characterized each with distinct effects on the immune response: CpG-A (‘D’-type), CpG-B (‘K’-type), and CpG-C. CpG-A ODN are characterized by poly-G motifs with phosphorotioate (PS) linkages at the 5’ and 3’ ends (facilitating cellular uptake) and a PO palindromic CpG-containing sequence in the ODN center. CpG-A ODN induces large amounts of IFN-alpha in PDC (unlike CpG-B), resulting in strong activation and IFN-gamma production in NK cells and gamma-delta T cells, but fails to activate B cells. Human monocytes exposed to the cytokine milieu elicited by CpG-A can differentiate into dendritic cells.
  • Amount:~200 nmol 20-mer CpG-A DNA (lot-specific).
  • Description:The prototype sequence of a CpG-A is the 20-mer ODN 2216 that mimics viral infection of PDC and is able to modulate the immune response in both human and mice. It has the following sequence: 5'-ggGGGACGATCGTCgggggG-3'. Lowercase letters represent PS linkage, uppercase letters represent PO linkage 3' of the base and bold letters represent CpG dinucleotides.
  • Applications:Suitable for use in biological assays in vitro to activate cells. Can also be used as an immune modulating agent. Other applications not tested.
  • Recommended Dilutions:In vitro Stimulation: 0.05-3uMOptimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:200nmol
  • Grade:Purified
  • Purity:Purified
  • Form:Supplied as a lyophilized powder. Endotoxin levels are undetectable. Reconstitute with sterile ddH2O.
  • Calc Applications Abbrev:E
  • EU Commodity Code:38220090
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1559-49
型番
C7905-80
入り数
1個
標準価格
183,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る